SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029562
Filing Date
2018-11-14
Accepted
2018-11-14 16:07:44
Documents
67
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-10q_20180930.htm 10-Q 1921990
2 EX-10.1 apvo-ex101_158.htm EX-10.1 4986596
3 EX-31.1 apvo-ex311_157.htm EX-31.1 19649
4 EX-31.2 apvo-ex312_156.htm EX-31.2 19481
5 EX-32.1 apvo-ex321_155.htm EX-32.1 10299
6 EX-32.2 apvo-ex322_154.htm EX-32.2 10407
7 GRAPHIC gnryjs1epzol000002.jpg GRAPHIC 3679
8 GRAPHIC gnryjs1epzol000001.jpg GRAPHIC 11042
  Complete submission text file 0001564590-18-029562.txt   12236027

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT apvo-20180930.xml EX-101.INS 1708685
10 XBRL TAXONOMY EXTENSION SCHEMA apvo-20180930.xsd EX-101.SCH 49557
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20180930_cal.xml EX-101.CAL 51461
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20180930_def.xml EX-101.DEF 162349
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20180930_lab.xml EX-101.LAB 360218
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20180930_pre.xml EX-101.PRE 279312
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 181183688
SIC: 2834 Pharmaceutical Preparations